Media corner
Here, media professionals will find the latest press releases, background information and other materials relating to Interpharma’s work and health policy issues.
Your contact persons
Our contact persons are available to answer media enquiries and provide information on our topics.
Latest press releases
Here you will find the latest press releases from Interpharma on current health policy issues, developments in research and the work of the association.
Press release: Pharmaceutical Industry Day 2026: Switzerland – a pharmaceutical hub at a crossroads
Read more
Press release – Bilaterals III: stable relationships with our principal trading partner
Read more
Press release: Research-based industries acknowledge the signing of free trade agreement with Mercosur
Read more
Further information
About Interpharma
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, represents the country’s strongest export sector. The market for pharmaceutical products sold abroad is valued around CHF 118 billion annually. In Switzerland, our member companies hold more than 90 % of the market share of patented medicines as well as almost two thirds of the total medicines market. They invest approximately CHF 9 billion in research and development in Switzerland annually.